Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
US Department of Justice
Chubb
Johnson and Johnson
Cipla
US Army
Daiichi Sankyo
Cerilliant

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203814

« Back to Dashboard

NDA 203814 describes SILDENAFIL CITRATE, which is a drug marketed by Aurobindo Pharma Ltd, Actavis Grp Ptc, Ajanta Pharma Ltd, Amneal Pharms, Apotex Corp, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Macleods Pharms Ltd, Mylan Pharms Inc, Rubicon Res Pvt Ltd, Teva, Teva Pharms, Torrent Pharms Ltd, and Watson Labs Inc, and is included in nineteen NDAs. It is available from thirty-one suppliers. Additional details are available on the SILDENAFIL CITRATE profile page.

The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 203814
Tradename:SILDENAFIL CITRATE
Applicant:Macleods Pharms Ltd
Ingredient:sildenafil citrate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 203814
Medical Subject Heading (MeSH) Categories for 203814
Suppliers and Packaging for NDA: 203814
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203814 ANDA Macleods Pharmaceuticals Limited 33342-121 N 33342-121-10
SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203814 ANDA Macleods Pharmaceuticals Limited 33342-121 N 33342-121-12

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Dec 17, 2013TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Accenture
Daiichi Sankyo
Express Scripts
Deloitte
Harvard Business School
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.